8.20
price up icon0.61%   0.05
after-market Dopo l'orario di chiusura: 8.36 0.16 +1.95%
loading

Terns Pharmaceuticals Inc Azioni (TERN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Costs And Expenses
0.16%
27.38
27.43 25.95 24.94 25.54
Operating Income/Loss
0.16%
-27.38
-27.43 -25.95 -24.94 -25.54
Nonoperating Income/Loss
7.01%
3.354
3.607 4.19 3.056 2.862
Income/Loss From Continuing Operations Before Tax
0.88%
-24.03
-23.82 -21.76 -21.88 -22.68
Income Tax Expense/Benefit
27.27%
0.064
0.088 0.04 0.062 0.061
Income/Loss From Continuing Operations After Tax
0.77%
-24.09
-23.91 -21.80 -21.95 -22.74
Net Income/Loss
0.77%
-24.09
-23.91 -21.80 -21.95 -22.74
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.11%
91.58
91.47 3.9396 77.82 74.46
Diluted Average Shares
0.11%
91.58
91.47 3.9396 77.82 74.46
Basic Earnings Per Share
0.00%
-0.26
-0.26 -0.23 -0.28 -0.31
Diluted Earnings Per Share
0.00%
-0.26
-0.26 -0.23 -0.28 -0.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):